PLMA 2024 ad 1

pharmacy

Pharmacists’ ever expanding role in diabetes care

Pharmacists’ ever expanding role in diabetes care

Diabetes and prediabetes persist as widespread conditions, demanding care in their own right and threatening complications from eye problems to kidney disease. Pharmacists offer accessible care and education for the nearly 40 million Americans with diabetes and close to 100 million with prediabetes. In this virtual roundtable, retailers and suppliers discuss  how pharmacists and the

Keystone introduces child resistant blister wallet, Push-PakÔ

Keystone introduces child resistant blister wallet, Push-PakÔ

NEWARK, NJ – Keystone Folding Box Co. has introduced a new paperboard blister wallet with push-through opening functionality. Push-PakÔ is an easy to open package, designed for tighter blister arrangement that reduces the package’s size. The blister wallet provides highest-possible F=1 child resistance while remaining easy to open for seniors and consumers with dexterity challenges.

Lumistry debuts software ecosystem for pharma communications

Lumistry debuts software ecosystem for pharma communications

AUSTIN, Texas — Lumistry has debuted its Second Screen software for pharmacies and its Digital Counter software for patients, an ecosystem of integrated and interoperable tools that address the challenges faced by independent pharmacies. With Lumistry’s platform, pharmacies and patients can manage prescriptions, appointments, messaging, forms, and tasks in one intuitive dashboard. This ecosystem streamlines

Pharmacy, pharmacist groups urge FDA to adopt phased approach to implementation of EDDS requirements of DSCSA

Pharmacy, pharmacist groups urge FDA to adopt phased approach to implementation of EDDS requirements of DSCSA

ARLINGTON, Va. – Organizations representing pharmacies and pharmacists are urging that the Food and Drug Administration (FDA) adopt a phased, stepwise approach to the implementation of the enhanced drug distribution security (EDDS) requirements of the Drug Supply Chain Security Act (DSCSA) that are scheduled to take effect on November 27, 2023. The action would go

Elixir launches specialty generic enhancement

Elixir launches specialty generic enhancement

PHILADELPHIA —  Elixir, a wholly owned subsidiary of Rite Aid, announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022. The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up

Avoiding pharmacy audits

Avoiding pharmacy audits

Pharmacy benefit managers (PBMs) regularly conduct audits on pharmacies to review their performance in relation to the PBM’s terms and conditions. There are several different types of compliance audits that PBMs may initiate, such as desktop, on-site, invoice or virtual. In order to be prepared for audits, pharmacies are encouraged to proactively undertake efforts to

Surescripts study reveals increased opportunities for technology

Surescripts study reveals increased opportunities for technology

ARLINGTON, Va. – Nearly half of pharmacists and two-thirds of prescribers report an increase in technology use over the past 18 months, according to a new Surescripts survey. The survey also found the majority of pharmacists and many prescribers believe the responsibilities of care providers, including nurses, physician assistants, physicians, specialists and non-clinical professionals, have

Hy-Vee working with RxSense

Hy-Vee working with RxSense

BOSTON – RxSense, the health care technology company improving transparency and access to affordable medications, announced it will power enterprise solutions for pharmacy benefits administration to Vivid Clear Rx, a subsidiary of Hy-Vee, Inc. Hy-Vee is one of the nation’s leading grocery chains with more than 275 stores spanning eight states across the Midwest. With

FDS and Amplicare ushering in the new era of pharmacy

FDS and Amplicare ushering in the new era of pharmacy

FORT WORTH, Texas  – FDS, a leading pharmacy technology company, and its subsidiary Amplicare, a provider of a decision-automation platform for healthcare providers, today announced significant growth and customer milestones, marking the dawn of a new era in the pharmacy market. In October 2020, Amplicare’s Medicare plan comparison platform, Amplicare Match, reported massive growth, onboarding nearly 200% more pharmacies compared

1 2 3 5
PP_1170x120_10-25-21